ŞANLIOĞLU, A. D. Et Al. 2008. Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death. 3. Klinik Pratikte Kök Hücre ve Gen Tedavisi Kongresi , (İstanbul, Turkey), 60.

ŞANLIOĞLU, A. D., DİRİCE, E., ELPEK, G. Ö., KORCUM, A. F., Özdoğan, M., SÜLEYMANLAR, İ., ... BALCI, M. K.(2008). Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death . 3. Klinik Pratikte Kök Hücre ve Gen Tedavisi Kongresi (pp.60). İstanbul, Turkey

ŞANLIOĞLU, AHTER Et Al. "Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death," 3. Klinik Pratikte Kök Hücre ve Gen Tedavisi Kongresi, İstanbul, Turkey, 2008

ŞANLIOĞLU, AHTER D. Et Al. "Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death." 3. Klinik Pratikte Kök Hücre ve Gen Tedavisi Kongresi , İstanbul, Turkey, pp.60, 2008

ŞANLIOĞLU, A. D. Et Al. (2008) . "Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death." 3. Klinik Pratikte Kök Hücre ve Gen Tedavisi Kongresi , İstanbul, Turkey, p.60.

@conferencepaper{conferencepaper, author={AHTER DİLŞAD ŞANLIOĞLU Et Al. }, title={Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death}, congress name={3. Klinik Pratikte Kök Hücre ve Gen Tedavisi Kongresi}, city={İstanbul}, country={Turkey}, year={2008}, pages={60} }